Cargando…
Identification of Immune Responses to Japanese Encephalitis Virus Specific T Cell Epitopes
Background: Due to the similarity between the dengue (DENV) and the Japanese encephalitis virus (JEV) there is potential for immune cross-reaction. We sought to identify T cell epitopes that are specific to JEV and do not cross react with DENV. Methodology: 20mer peptides were synthesized from regio...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029616/ https://www.ncbi.nlm.nih.gov/pubmed/32117854 http://dx.doi.org/10.3389/fpubh.2020.00019 |
_version_ | 1783499208043528192 |
---|---|
author | Pushpakumara, Pradeep Darshana Jeewandara, Chandima Wijesinghe, Ayesha Gomes, Laksiri Ogg, Graham S. Goonasekara, Charitha Lakshini Malavige, Gathsaurie Neelika |
author_facet | Pushpakumara, Pradeep Darshana Jeewandara, Chandima Wijesinghe, Ayesha Gomes, Laksiri Ogg, Graham S. Goonasekara, Charitha Lakshini Malavige, Gathsaurie Neelika |
author_sort | Pushpakumara, Pradeep Darshana |
collection | PubMed |
description | Background: Due to the similarity between the dengue (DENV) and the Japanese encephalitis virus (JEV) there is potential for immune cross-reaction. We sought to identify T cell epitopes that are specific to JEV and do not cross react with DENV. Methodology: 20mer peptides were synthesized from regions which showed >90% conservation. Using IFNγ cultured ELISpot assays, we investigated JEV-specific T cell responses in DENV(−) and JEV(−) non-immune individuals (DENV(−)JEV(−) = 21), JEV seronegative and had not received the JE vaccine, but who were DENV seropositive (DENV(+)JEV(−) = 22), JEV(+)(seropositive for JEV and had received the JE vaccine), but seronegative for DENV (DENV(−)JEV(+) = 23). We further assessed the responses to these peptides by undertaking ex vivo IFNγ assays and flow cytometry. Results: None of DENV(−)JEV(−) individuals responded to any of the 20 JEV-specific peptides. High frequency of responses was seen to 6/20 peptides by individuals who were JEV(+) but DENV(−), where over 75% of the individuals responded to at least one peptide. P34 was the most immunogenic peptide, recognized by 20/23 (86.9%) individuals who were DENV(−)JEV(+), followed by peptide 3 and peptide 7 recognized by 19/23 (82.6%). Peptide 34 from the NS2a region, showed <25% homology with any flaviviruses, and <20% homology with any DENV serotype. Peptide 20 and 32, which were also from the non-structural protein regions, showed <25% homology with DENV. Ex vivo responses to these peptides were less frequent, with only 40% of individuals responding to peptide 34 and 16–28% to other peptides, probably as 5/6 peptides were recognized by CD4+ T cells. Discussion: We identified six highly conserved, T cell epitopes which are highly specific for JEV, in the Sri Lankan population. Since both JEV and DENV co-circulate in the same regions and since both JE and dengue vaccines are likely to be co-administered in the same geographical regions in future, these JEV-specific T cell epitopes would be useful to study JEV-specific T cell responses, in order to further understand how DENV and JEV-specific cellular immune responses influence each other. |
format | Online Article Text |
id | pubmed-7029616 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-70296162020-02-28 Identification of Immune Responses to Japanese Encephalitis Virus Specific T Cell Epitopes Pushpakumara, Pradeep Darshana Jeewandara, Chandima Wijesinghe, Ayesha Gomes, Laksiri Ogg, Graham S. Goonasekara, Charitha Lakshini Malavige, Gathsaurie Neelika Front Public Health Public Health Background: Due to the similarity between the dengue (DENV) and the Japanese encephalitis virus (JEV) there is potential for immune cross-reaction. We sought to identify T cell epitopes that are specific to JEV and do not cross react with DENV. Methodology: 20mer peptides were synthesized from regions which showed >90% conservation. Using IFNγ cultured ELISpot assays, we investigated JEV-specific T cell responses in DENV(−) and JEV(−) non-immune individuals (DENV(−)JEV(−) = 21), JEV seronegative and had not received the JE vaccine, but who were DENV seropositive (DENV(+)JEV(−) = 22), JEV(+)(seropositive for JEV and had received the JE vaccine), but seronegative for DENV (DENV(−)JEV(+) = 23). We further assessed the responses to these peptides by undertaking ex vivo IFNγ assays and flow cytometry. Results: None of DENV(−)JEV(−) individuals responded to any of the 20 JEV-specific peptides. High frequency of responses was seen to 6/20 peptides by individuals who were JEV(+) but DENV(−), where over 75% of the individuals responded to at least one peptide. P34 was the most immunogenic peptide, recognized by 20/23 (86.9%) individuals who were DENV(−)JEV(+), followed by peptide 3 and peptide 7 recognized by 19/23 (82.6%). Peptide 34 from the NS2a region, showed <25% homology with any flaviviruses, and <20% homology with any DENV serotype. Peptide 20 and 32, which were also from the non-structural protein regions, showed <25% homology with DENV. Ex vivo responses to these peptides were less frequent, with only 40% of individuals responding to peptide 34 and 16–28% to other peptides, probably as 5/6 peptides were recognized by CD4+ T cells. Discussion: We identified six highly conserved, T cell epitopes which are highly specific for JEV, in the Sri Lankan population. Since both JEV and DENV co-circulate in the same regions and since both JE and dengue vaccines are likely to be co-administered in the same geographical regions in future, these JEV-specific T cell epitopes would be useful to study JEV-specific T cell responses, in order to further understand how DENV and JEV-specific cellular immune responses influence each other. Frontiers Media S.A. 2020-02-12 /pmc/articles/PMC7029616/ /pubmed/32117854 http://dx.doi.org/10.3389/fpubh.2020.00019 Text en Copyright © 2020 Pushpakumara, Jeewandara, Wijesinghe, Gomes, Ogg, Goonasekara and Malavige. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Public Health Pushpakumara, Pradeep Darshana Jeewandara, Chandima Wijesinghe, Ayesha Gomes, Laksiri Ogg, Graham S. Goonasekara, Charitha Lakshini Malavige, Gathsaurie Neelika Identification of Immune Responses to Japanese Encephalitis Virus Specific T Cell Epitopes |
title | Identification of Immune Responses to Japanese Encephalitis Virus Specific T Cell Epitopes |
title_full | Identification of Immune Responses to Japanese Encephalitis Virus Specific T Cell Epitopes |
title_fullStr | Identification of Immune Responses to Japanese Encephalitis Virus Specific T Cell Epitopes |
title_full_unstemmed | Identification of Immune Responses to Japanese Encephalitis Virus Specific T Cell Epitopes |
title_short | Identification of Immune Responses to Japanese Encephalitis Virus Specific T Cell Epitopes |
title_sort | identification of immune responses to japanese encephalitis virus specific t cell epitopes |
topic | Public Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029616/ https://www.ncbi.nlm.nih.gov/pubmed/32117854 http://dx.doi.org/10.3389/fpubh.2020.00019 |
work_keys_str_mv | AT pushpakumarapradeepdarshana identificationofimmuneresponsestojapaneseencephalitisvirusspecifictcellepitopes AT jeewandarachandima identificationofimmuneresponsestojapaneseencephalitisvirusspecifictcellepitopes AT wijesingheayesha identificationofimmuneresponsestojapaneseencephalitisvirusspecifictcellepitopes AT gomeslaksiri identificationofimmuneresponsestojapaneseencephalitisvirusspecifictcellepitopes AT ogggrahams identificationofimmuneresponsestojapaneseencephalitisvirusspecifictcellepitopes AT goonasekaracharithalakshini identificationofimmuneresponsestojapaneseencephalitisvirusspecifictcellepitopes AT malavigegathsaurieneelika identificationofimmuneresponsestojapaneseencephalitisvirusspecifictcellepitopes |